Skip to content

GENERIX GROUP BENELUX

Active Public limited companyfounded 1997active for 29 yearsDerbystraat 377, 9051 GhentKBO/BCE: BE 0459.718.731 subsidiary of Generix Group SAS

Board

2 directors, 2 in day-to-day management, 1 auditor, last change in August 2026
Director and managing director
director since 26-02-2024 managing director appointed by deed of 23-07-2024 6-year term from 2024
listed in the 2025 annual accounts, filed on 29-12-2025
Director and managing director
appointed by deed of 06-10-2026
Statutory auditor, permanent representative Martine Vermeersch
appointed by deed of 05-12-2024
Raphaël SANCHEZ, Benoit VOITURIEZ
Signing authorityThe articles say who may bind the company, for example by signing a contract.
Each director alone
deed of 05-12-2024

Office holders in the KBO →

Mandates through the years

12 names, the dashed line is today
Raphaël SANCHEZ
Director, Managing director
Benoit VOITURIEZ
Director, Managing director
Ludovic LUZZA
Managing director
Mazars Bedrijfsrevisoren
Statutory auditor
Aïda Aïssatou SENE
Managing director
Jean-Charles DECONNINCK
Managing director
Verva VOF
Director
LeadershipBoardEarlierRest of the termmandate already running before its first mention
Mandates as a list
  • Raphaël SANCHEZ
    • Director, from 26-02-2024 to date
    • Managing director, appointed by deed of 23-07-2024, still in office
  • Benoit VOITURIEZ
    • Director, appointed by deed of 06-10-2026, still in office
    • Managing director, appointed by deed of 06-10-2026, still in office
  • Forvis Mazars Réviseurs d’Entreprises
    • Statutory auditor, from 30-09-2023 to date
  • Ludovic LUZZA
    • Director, from 27-02-2019 to 19-11-2022
    • Director, appointed by deed of 29-12-2025, until 31-08-2026
    • Managing director, appointed by deed of 29-12-2025, until 31-08-2026
  • François THERY
    • Director, appointed by deed of 01-02-2022, until 29-12-2025
  • Mazars Bedrijfsrevisoren
    • Statutory auditor, appointed by deed of 03-10-2018, until 05-12-2024
  • Aïda Aïssatou SENE
    • Director, from 27-02-2019 to 26-02-2024
    • Managing director, appointed by deed of 25-01-2023, until 26-02-2024
  • Jean-Charles DECONNINCK
    • Managing director, from 30-09-2020 to 25-01-2023
  • Gabriel Blanc-Lainé
    • Director, until 01-02-2022
  • Carla Schoorens
    • Board, appointed by deed of 12-04-2021, until 07-01-2022
  • Verva VOF
    • Director, appointed by deed of 18-02-2019, until 12-04-2021
  • Christiaan Van der Schueren
    • Director, until 03-10-2018

Control

Consolidating parent
Generix Group SAS FR
consolidates
This company
GENERIX GROUP BENELUX
Equity €350,008
Profit €52,279 in 2025

Capital

Capital
€61,973.38
Shares
8,760
Contribution per share
€7.07
Equity per share
€39.96 in 2025
Source
deed of 05-12-2024

Owners through the years

as the annual accounts name them
Generix Group SAS FR
consolidates
Generix SA FR
consolidates until 2022
Owners as a list

Source: parent in its own accounts

Articles of association

deed of 05-12-2024 (in Dutch)
Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 3 directors
Term of at most 6 years
“Raad kiest uit midden voorzitter, Voorzitterschap van de raad van bestuur”
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
First Wednesday of September at 11:00

Next steps